By Anne Urda ( March 10, 2008, 12:00 AM EDT) -- As the first state trial over Zyprexa begins to unfold, a former officer with the U.S. Food and Drug Administration has asserted that Eli Lilly & Co. brushed off the risks associated with the popular schizophrenia drug in order to continue raking in profits from the medication's sale....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.